This inventor holds 5 USPTO granted patents and 2 EPO patents. Top assignees: Lasergen, Inc., Agilent Technologies, Inc.. Active years: 2014-2021.
Company Filing History:
Years Active: 2014-2021
Title: The Innovative Contributions of David Hertzog
Introduction
David Hertzog is a notable inventor based in Houston, TX (US), recognized for his significant contributions to the field of nucleic acid sequencing. With a total of 5 patents, Hertzog has made strides in developing advanced methodologies that enhance the efficiency and accuracy of DNA and RNA analysis.
Latest Patents
One of Hertzog's latest patents is titled "3'-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing." This invention focuses on 3'-OH unblocked nucleotides and nucleosides that are labeled and unlabeled with 5-methoxy-substituted nitrobenzyl-based photocleavable terminating groups. These compounds are designed for use in systems related to DNA and RNA sequencing and analysis. They serve as reversible terminators, exhibiting fast nucleotide incorporation kinetics, single-base termination, high nucleotide selectivity, and rapid terminating group cleavage, resulting in naturally occurring nucleotides.
Career Highlights
Throughout his career, Hertzog has worked with prominent companies such as Lasergen, Inc. and Agilent Technologies, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in the field of biotechnology.
Collaborations
Hertzog has collaborated with notable colleagues, including Weidong Wu and Megan N Hersh. These partnerships have further enriched his work and expanded the impact of his inventions.
Conclusion
David Hertzog's innovative work in nucleic acid sequencing exemplifies the importance of advancements in biotechnology. His patents and collaborations continue to influence the field, paving the way for future discoveries and applications.